Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
obesity drugs
Marketing
A patient-first shift in disease language and communication
From mpox to obesity, outdated and imprecise disease labels can deepen stigma, delay care and complicate diagnosis.
Ben Adams
Jun 3, 2026 11:35am
The Oral GLP-1 Tracker: Jefferies reaffirms Foundayo forecast
Jun 1, 2026 9:23am
CVS will cover Eli Lilly obesity products Zepbound and Foundayo
May 28, 2026 11:20am
CordenPharma to snap up peptide API maker with US, China sites
May 27, 2026 10:39am
Trump bought stock in drugmaker as admin boosted its obesity drugs
May 19, 2026 8:47am
Novo, Lilly unveil new obesity data as GLP-1 rivalry grows
May 13, 2026 11:18am
